Top compounds associated with response to SPATA25


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.05
mRNA pac-1 CTRPv2 pan-cancer AAC 0.07 0.05
mRNA manumycin A CTRPv2 pan-cancer AAC 0.062 0.05
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.074 0.05
mRNA lovastatin CTRPv2 pan-cancer AAC -0.071 0.05
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.067 0.05
mRNA tivozanib GDSC1000 pan-cancer AAC 0.065 0.06
mRNA birinapant CTRPv2 pan-cancer AAC -0.072 0.06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA YM-155 GDSC1000 pan-cancer AAC -0.063 0.06
Download CSV